TrialCheck® - eviti® Integration Brings Clinical Trials to the Point of Care

Share Article

Sharing a common philosophy that physicians, patients and payers should consider clinical trials as a viable treatment option; these two organizations have agreed to integrate the TrialCheck cancer clinical trials database into the eviti oncology decision-support platform. The new relationship will bring clinical trial options to the normal workflow of the medical practice, giving physicians even more treatment options at the point of prescribing.

News Image
A tool as precise as TrialCheck is most effective when integrated into the normal workflow of the medical practice – where the key interactions among patients, physicians and payers take place.

ITA Partners, Inc. and the Coalition of Cancer Cooperative Groups today announced that they have reached an agreement in which ITA has acquired ownership of TrialCheck® – the leading cancer clinical trial search engine – from the Coalition. The TrialCheck database will be merged into ITA’s oncology decision-support platform – eviti® – which currently contains nearly 1,000 treatment guidelines for 120+ types of cancer; and TrialCheck will remain available to the public via the Coalition website http://www.CancerTrialsHelp.org through a licensing arrangement.

“In our quest to be the most comprehensive oncology decision-support resource, accessible by every oncologist, to treat every cancer patient; we are constantly evolving eviti. This acquisition and integration of the clinical trials database is the ideal next step in providing a holistic approach to oncology treatment options,” said Eduardo Beruff, chief executive officer and president of ITA.

As new health care laws will soon require payers to reimburse for clinical trials, the need arises to determine a trial’s appropriateness for each patient. The integration of the TrialCheck database into eviti, not only meets the need, but benefits all parties involved:

  •      Patients receive assurance that their physician will identify and suggest appropriate clinical trials as part of their full range of treatment options;
  •      Physicians have access to the latest nationally-recognized evidence-based treatment options, including clinical trials that may be beneficial for the patient;
  •      Payers are assured that the options presented through eviti, including clinical trials, fit the patient’s diagnosis, and that they are reimbursing for appropriate care.

The Coalition and ITA share a common philosophy that physicians, patients and payers should consider clinical trials as a viable treatment option; and integrating the TrialCheck database into eviti brings clinical trial options to the forefront, giving physicians even more treatment options at the point of prescribing.

“Strategically, we knew all along that in order to make clinical trials part of the treatment paradigm, a tool as precise as TrialCheck would be most effective when integrated into the normal workflow of the medical practice – where the key interactions among patients, physicians and payers take place.” said Robert L. Comis, MD, president and chairman of the Coalition. “The match with eviti is a perfect fit. While ITA has identified trial searching and protocol navigation as essential components of its product offering, it has not yet developed such a tool. The match repositions TrialCheck to become an integral component of a larger evidence-based prescribing approach.”

About eviti

eviti is a unique platform that, in real time, aligns physician and payer priorities at the point of care to ensure the most appropriate, evidence-based oncology treatment is administered from the start. ITA’s independent, non-proprietary digital oncology treatment library is one of the most comprehensive of its kind. It comprises nearly 1,000 of the most appropriate, proven treatment options covering all modalities for 120+ cancer types compiled from the world’s leading sources. eviti’s treatment knowledge base and decision-support engine help oncologists select a treatment option that is both evidence-based and compliant with each patient’s insurance plan language at the moment of prescribing. This transparent approach streamlines workflow and reimbursement, reduces variability in clinical care, and results in cost efficiencies to benefit all participants in cancer treatment. For more information, visit http://www.itapartners.com/eviti.

About TrialCheck

TrialCheck is the leading cancer clinical trial search engine created in 2001 by the Coalition of Cancer Cooperative Groups and publicly available at http://www.CancerTrialsHelp.org. TrialCheck continuously imports information for all cancer clinical studies federally registered with the U.S. Government Department of Health and Human Services via its databases ClinicalTrials.gov, a service of the National Institutes of Health, and Physician Data Query (PDQ®), a cancer database of the National Cancer Institute. Daily quality control processes ensure that the information is accurate and reliable. Using TrialCheck’s unique screening filter, people can obtain tailored information on clinically appropriate, open and enrolling, trials for patients in hospitals, cancer centers and oncology practices across the US and throughout the world.

For more information, visit http://www.itapartners.com and http://www.CancerTrialsHelp.org.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Diane Colaizzi
Coalition of Cancer Cooperative Groups
215-789-3612
Email >

Traci Boehringer
ITA Partners, Inc.
215-569-0656 196
Email >
Visit website